Literature DB >> 26893310

Early-Onset Mild Type Leukoencephalopathy Caused by a Homozygous EARS2 Mutation.

Birce Dilge Taskin1, Zeynep Selen Karalok2, Esra Gurkas2, Kursad Aydin3, Ummu Aydogmus2, Serdar Ceylaner4, Kadri Karaer5, Cahide Yilmaz2, Phillip Lawrence Pearl6.   

Abstract

Childhood leukoencephalopathies are a broad class of diseases, which are extremely rare. The treatment and classification of these disorders are both challenging. Nearly half of children presenting with a leukoencephalopathy remain without a specific diagnosis. Leukoencephalopathy with thalamus and brain stem involvement and high lactate (LTBL) is a newly described childhood leukoencephalopathy caused by mutations in the gene encoding a mitochondrial aminoacyl-tRNA synthetase specific for glutamate, EARS2 Magnetic resonance images show a characteristic leukoencephalopathy with thalamic and brain stem involvement. Here, we report a different clinical course of LTBL supported by typical MRI features in a Turkish patient who presented with a history of failure to walk. The EARS2 gene mutation analysis identified a c.322C>T transition, predicting a p.R108W change. This is the first reported early-onset mild type LTBL caused by a homozygous EARS2 mutation case in the literature.
© The Author(s) 2016.

Entities:  

Keywords:  leukoencephalopathy; magnetic resonance imaging (MRI); mitochondrial DNA translation; mitochondrial aminoacyl–transfer RNA synthetase; mitochondrial disease

Mesh:

Substances:

Year:  2016        PMID: 26893310      PMCID: PMC6020828          DOI: 10.1177/0883073816630087

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

Review 1.  Strategies for treating mitochondrial disorders: an update.

Authors:  Mauro Scarpelli; Alice Todeschini; Fabrizio Rinaldi; Silvia Rota; Alessandro Padovani; Massimiliano Filosto
Journal:  Mol Genet Metab       Date:  2014-10-08       Impact factor: 4.797

2.  DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.

Authors:  Nicole I Wolf; Camilo Toro; Ilya Kister; Kartikasalwah Abd Latif; Richard Leventer; Amy Pizzino; Cas Simons; Truus E M Abbink; Ryan J Taft; Marjo S van der Knaap; Adeline Vanderver
Journal:  Neurology       Date:  2014-12-19       Impact factor: 9.910

3.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

Authors:  Albena Jordanova; Joy Irobi; Florian P Thomas; Patrick Van Dijck; Kris Meerschaert; Maarten Dewil; Ines Dierick; An Jacobs; Els De Vriendt; Velina Guergueltcheva; Chitharanjan V Rao; Ivailo Tournev; Francisco A A Gondim; Marc D'Hooghe; Veerle Van Gerwen; Patrick Callaerts; Ludo Van Den Bosch; Jean-Pièrre Timmermans; Wim Robberecht; Jan Gettemans; Johan M Thevelein; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

4.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

5.  A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.

Authors:  Philippe Latour; Christel Thauvin-Robinet; Chantal Baudelet-Méry; Pierre Soichot; Veronica Cusin; Laurence Faivre; Marie-Claire Locatelli; Martine Mayençon; Annie Sarcey; Emmanuel Broussolle; William Camu; Albert David; Robert Rousson
Journal:  Am J Hum Genet       Date:  2009-12-31       Impact factor: 11.025

6.  Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.

Authors:  Ryan J Taft; Adeline Vanderver; Richard J Leventer; Stephen A Damiani; Cas Simons; Sean M Grimmond; David Miller; Johanna Schmidt; Paul J Lockhart; Kate Pope; Kelin Ru; Joanna Crawford; Tena Rosser; Irenaeus F M de Coo; Monica Juneja; Ishwar C Verma; Prab Prabhakar; Susan Blaser; Julian Raiman; Petra J W Pouwels; Marianna R Bevova; Truus E M Abbink; Marjo S van der Knaap; Nicole I Wolf
Journal:  Am J Hum Genet       Date:  2013-05-02       Impact factor: 11.025

7.  Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation.

Authors:  Beril Talim; Angela Pyle; Helen Griffin; Haluk Topaloglu; Aysegul Tokatli; Michael J Keogh; Mauro Santibanez-Koref; Patrick F Chinnery; Rita Horvath
Journal:  Brain       Date:  2012-09-24       Impact factor: 13.501

8.  Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.

Authors:  Marjan E Steenweg; Daniele Ghezzi; Tobias Haack; Truus E M Abbink; Diego Martinelli; Carola G M van Berkel; Annette Bley; Luisa Diogo; Eugenio Grillo; Johann Te Water Naudé; Tim M Strom; Enrico Bertini; Holger Prokisch; Marjo S van der Knaap; Massimo Zeviani
Journal:  Brain       Date:  2012-04-04       Impact factor: 13.501

9.  Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.

Authors:  Robert Kopajtich; Thomas J Nicholls; Joanna Rorbach; Metodi D Metodiev; Peter Freisinger; Hanna Mandel; Arnaud Vanlander; Daniele Ghezzi; Rosalba Carrozzo; Robert W Taylor; Klaus Marquard; Kei Murayama; Thomas Wieland; Thomas Schwarzmayr; Johannes A Mayr; Sarah F Pearce; Christopher A Powell; Ann Saada; Akira Ohtake; Federica Invernizzi; Eleonora Lamantea; Ewen W Sommerville; Angela Pyle; Patrick F Chinnery; Ellen Crushell; Yasushi Okazaki; Masakazu Kohda; Yoshihito Kishita; Yoshimi Tokuzawa; Zahra Assouline; Marlène Rio; François Feillet; Bénédict Mousson de Camaret; Dominique Chretien; Arnold Munnich; Björn Menten; Tom Sante; Joél Smet; Luc Régal; Abraham Lorber; Asaad Khoury; Massimo Zeviani; Tim M Strom; Thomas Meitinger; Enrico S Bertini; Rudy Van Coster; Thomas Klopstock; Agnès Rötig; Tobias B Haack; Michal Minczuk; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2014-11-26       Impact factor: 11.025

  9 in total
  6 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Metabolic impact of pathogenic variants in the mitochondrial glutamyl-tRNA synthetase EARS2.

Authors:  Min Ni; Lauren F Black; Chunxiao Pan; Hieu Vu; Jimin Pei; Bookyung Ko; Ling Cai; Ashley Solmonson; Chendong Yang; Kimberly M Nugent; Nick V Grishin; Chao Xing; Elizabeth Roeder; Ralph J DeBerardinis
Journal:  J Inherit Metab Dis       Date:  2021-04-27       Impact factor: 4.750

3.  Identification of a Novel Variant in EARS2 Associated with a Severe Clinical Phenotype Expands the Clinical Spectrum of LTBL.

Authors:  Sofia Barbosa-Gouveia; Emiliano González-Vioque; Álvaro Hermida; María Unceta Suarez; María Jesús Martínez-González; Filipa Borges; Liesbeth Wintjes; Antonia Kappen; Richard Rodenburg; María-Luz Couce
Journal:  Genes (Basel)       Date:  2020-09-02       Impact factor: 4.096

4.  Lethal Neonatal LTBL Associated with Biallelic EARS2 Variants: Case Report and Review of the Reported Neuroradiological Features.

Authors:  Renata Oliveira; Ewen W Sommerville; Kyle Thompson; Joana Nunes; Angela Pyle; Manuela Grazina; Patrick F Chinnery; Luísa Diogo; Paula Garcia; Robert W Taylor
Journal:  JIMD Rep       Date:  2016-08-30

Review 5.  Mitochondrial Protein Translation: Emerging Roles and Clinical Significance in Disease.

Authors:  Fei Wang; Deyu Zhang; Dejiu Zhang; Peifeng Li; Yanyan Gao
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 6.  Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.

Authors:  Amena Smith Fine; Christina L Nemeth; Miriam L Kaufman; Ali Fatemi
Journal:  J Neurodev Disord       Date:  2019-12-16       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.